ArticleFrontiers in medicine2025

Pentraxin-3 as a poor marker of fibrosis in metabolic dysfunction-associated steatotic liver disease among older adults: findings from the PolSenior2 substudy.

Aleksander Jerzy Owczarek et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.